William Bertrand
2017
In 2017, William Bertrand earned a total compensation of $2M as Chief Operating Officer at Adaptimmune Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $128,250 |
|---|---|
| Option Awards | $1,517,348 |
| Salary | $316,666 |
| Other | $34,192 |
| Total | $1,996,456 |
Bertrand received $1.5M in option awards, accounting for 76% of the total pay in 2017.
Bertrand also received $128.3K in non-equity incentive plan, $316.7K in salary and $34.2K in other compensation.
Rankings
In 2017, William Bertrand's compensation ranked 5,511th out of 14,666 executives tracked by ExecPay. In other words, Bertrand earned more than 62.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,511 out of 14,666 | 62nd |
Division Manufacturing | 1,984 out of 5,772 | 66th |
Major group Chemicals And Allied Products | 601 out of 2,075 | 71st |
Industry group Drugs | 463 out of 1,731 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 88 out of 313 | 72nd |
Source: SEC filing on March 15, 2019.
Bertrand's colleagues
We found four more compensation records of executives who worked with William Bertrand at Adaptimmune Therapeutics in 2017.